S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Is Graphite the New Lithium? (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
How to Invest in AI's Fast-Growing Market (Ad)
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Okta, Inc: When Great Results Aren’t Good Enough 
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Is Graphite the New Lithium? (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
How to Invest in AI's Fast-Growing Market (Ad)
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Okta, Inc: When Great Results Aren’t Good Enough 
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Is Graphite the New Lithium? (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
How to Invest in AI's Fast-Growing Market (Ad)
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Okta, Inc: When Great Results Aren’t Good Enough 
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Is Graphite the New Lithium? (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
How to Invest in AI's Fast-Growing Market (Ad)
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Okta, Inc: When Great Results Aren’t Good Enough 
NASDAQ:NVAX

Novavax (NVAX) Earnings Date, Estimates & Call Transcripts

$7.72
-0.33 (-4.10%)
(As of 06/1/2023 ET)
Compare
Today's Range
$7.56
▼
$8.19
50-Day Range
$6.04
▼
$9.52
52-Week Range
$5.61
▼
$76.77
Volume
3.62 million shs
Average Volume
6.68 million shs
Market Capitalization
$666.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$70.67
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 9)
-$3.41 Missed By -$0.03
Consensus EPS
(May. 9)
-$3.38
Last Year's Q2 EPS
(5/9/2022)
$2.56
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NVAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVAX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novavax Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233($3.68)($3.08)($3.45) 
Q2 20234($1.94)($1.13)($1.62) 
Q3 20234($1.51)$1.49($0.39) 
Q4 20234($0.36)$2.25$1.07 
FY 202315($7.49)($0.47)($4.39) 
Q1 20241($0.99)($0.99)($0.99) 
Q2 20241($0.62)($0.62)($0.62) 
Q3 20241($0.41)($0.41)($0.41) 
Q4 20241($0.18)($0.18)($0.18) 
FY 20244($2.20)($2.20) ($2.20)

NVAX Earnings Date and Information

Novavax last posted its earnings data on May 9th, 2023. The biopharmaceutical company reported ($3.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.38) by $0.03. The business had revenue of $81 million for the quarter, compared to analyst estimates of $94.52 million. Its quarterly revenue was down 88.5% compared to the same quarter last year. Novavax has generated ($14.37) earnings per share over the last year (($14.37) diluted earnings per share). Earnings for Novavax are expected to grow in the coming year, from ($2.76) to ($1.55) per share. Novavax has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off prior year's report dates.

Novavax Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2023
(Estimated)		        
5/9/2023Q1 23($3.38)($3.41)($0.03)($3.41)$94.52 million$81.00 million      
2/28/2023Q4 22($0.92)($2.28)($1.36)($2.28)$383.14 million$357.40 million    
11/8/2022Q3 2022$2.21($2.15)($4.36)($2.15)$555.50 million$734.58 million      
8/8/2022Q2 2022$5.51($6.53)($12.04)($6.53)$1.02 billion$186.00 million    
5/9/2022Q1 2022$3.33$2.56($0.77)$2.56$845.20 million$703.97 million    
2/28/2022Q4 2021($1.43)($11.18)($9.75)($11.18)$331.79 million$222.20 million    
11/4/20219/30/2021($4.04)($4.31)($0.27)($4.31)$347.34 million$178.80 million    
8/5/20216/30/2021($3.63)($4.75)($1.12)($4.75)$370.80 million$298.02 million    
5/10/20213/31/2021($2.65)($3.05)($0.40)($3.05)$233.90 million$447.00 million  
3/1/202112/31/2020($1.53)($2.70)($1.17)($2.70)$202.44 million$279.66 million  
11/9/20209/30/2020$2.36($3.21)($5.57)($3.21)$230.56 million$157.00 million  
8/10/20206/30/2020($0.60)($0.30)+$0.30($0.30)$5.67 million$35.50 million  
5/11/20203/31/2020($0.67)($0.58)+$0.09($0.58)$3.50 million$3.38 million  
3/11/202012/31/2019($1.06)($1.13)($0.07)($1.13)$3.99 million$8.82 million  
11/7/2019Q3 19($0.98)($0.74)+$0.24($1.32)$4.40 million$2.51 million  
8/7/2019Q2 2019($1.61)($1.69)($0.08)($1.69)$3.53 million$3.36 million
5/2/20193/31/2019($2.40)($2.20)+$0.20($0.11)$4.80 million$3.98 million  
3/18/201912/31/2018($2.40)($2.60)($0.20)($0.13)$7.87 million$6.13 million  
11/7/20189/30/2018($2.40)($2.40)($0.12)$9.63 million$7.70 million  
8/8/2018Q2 2018($2.40)($2.40)($0.12)$10.02 million$10.80 million
5/9/2018Q1 18($2.60)($2.80)($0.20)($0.14)$9.33 million$9.70 million
3/14/2018Q4 17($3.00)($3.20)($0.20)($0.16)$7.98 million$10.40 million  
11/7/2017Q3 2017($3.20)($3.00)+$0.20($0.15)$6.42 million$8.35 million
8/8/2017Q2 2017($3.20)($3.20)($0.16)$6.15 million$6.70 million  
5/8/2017Q1 2017($3.60)($3.20)+$0.40($0.16)$6.17 million$5.68 million  
2/27/2017Q416($4.60)($4.20)+$0.40($0.21)$5.45 million$5.40 million  
11/9/2016Q316($5.20)($4.80)+$0.40($0.24)$4.02 million$3.20 million  
8/9/2016Q216($5.00)($5.80)($0.80)($0.29)$8.03 million$2.50 million  
5/4/2016Q1($5.40)($5.80)($0.40)($0.29)$10.39 million$4.20 million  
2/29/2016Q415($2.80)($5.80)($3.00)($0.29)$8.07 million$5.90 million  
11/9/2015Q315($1.80)($2.40)($0.60)($0.12)$10.59 million$6.50 million
8/10/2015Q215($1.80)($1.60)+$0.20($0.08)$9.90 million$14.00 million  
5/7/2015Q115($2.20)($2.00)+$0.20($0.10)$9.70 million$9.88 million
2/26/2015Q4 14($1.60)($2.60)($1.00)($0.13)$9.60 million$6.70 million
11/5/2014Q314($1.40)($1.60)($0.20)($0.08)$9.20 million$8.20 million
8/6/2014Q214($1.40)($1.60)($0.20)($0.08)$8.74 million$8.26 million  
5/7/2014Q114($1.40)($1.40)($0.07)$3.80 million$7.50 million
3/10/2014Q4 2013($1.40)($1.40)($0.07)$6.22 million$8.70 million
11/7/2013Q3 2013($1.20)($1.80)($0.60)($0.09)$4.56 million$4.80 million
8/8/2013Q2 2013($1.00)($1.60)($0.60)($0.08)$4.45 million$3.50 million
5/7/2013Q1 2013($0.80)($1.40)($0.60)($0.07)$5.54 million$3.80 million
3/1/2013Q4 2012($0.80)($1.20)($0.40)$5.85 million$4.57 million  
11/2/2012Q312($1.00)($1.00)$7.59 million$5.80 million
8/3/2012($1.40)($1.00)+$0.40
5/4/2012($0.80)($1.20)($0.40)
3/9/2012($0.80)($0.60)+$0.20
11/4/2011($1.20)($0.60)+$0.60  
8/5/2011($1.60)($0.80)+$0.80  
5/9/2011($1.40)($1.40)  
3/28/2011($1.80)($1.20)+$0.60  
11/5/2010Q3 2010($1.80)($2.00)($0.20)($0.10)
8/6/2010Q2 2010($2.00)($1.80)+$0.20($0.09)
5/10/2010Q1 2010($2.60)($2.20)+$0.40($0.11)
3/12/2010Q4 2009($0.80)($3.00)($2.20)($0.15)
11/6/2009Q3 2009($1.80)($1.60)+$0.20($0.08)
8/7/2009Q2 2009($2.20)($2.00)+$0.20($0.10)
5/8/2009Q1 2009($2.40)($2.40)($0.12)
3/31/2009Q4 2008($2.60)($2.20)+$0.40($0.07)
11/10/2008Q3 2008($2.80)($3.20)($0.40)($0.20)
8/8/2008Q2 2008($2.80)($2.80)($0.13)
5/9/2008Q1 2008($2.40)($2.40)($0.11)
3/14/2008Q4 2007($2.60)($2.20)+$0.40($0.07)












Novavax Earnings - Frequently Asked Questions

When is Novavax's earnings date?

Novavax has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off last year's report dates. Learn more on NVAX's earnings history.

Did Novavax beat their earnings estimates last quarter?

In the previous quarter, Novavax (NASDAQ:NVAX) missed the analysts' consensus estimate of ($3.38) by $0.03 with a reported earnings per share (EPS) of ($3.41). Learn more on analysts' earnings estimate vs. NVAX's actual earnings.

How can I listen to Novavax's earnings conference call?

The conference call for Novavax's latest earnings report can be listened to online. Listen to Conference Call

How can I read Novavax's conference call transcript?

The conference call transcript for Novavax's latest earnings report can be read online. Read Transcript

How can I view Novavax's earnings report?

Novavax's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Novavax generate each year?

Novavax (NASDAQ:NVAX) has a recorded annual revenue of $1.37 billion.

How much profit does Novavax generate each year?

Novavax (NASDAQ:NVAX) has a recorded net income of -$657.94 million. NVAX has generated -$14.37 earnings per share over the last four quarters.

What is Novavax's EPS forecast for next year?

Novavax's earnings are expected to grow from ($2.76) per share to ($1.55) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:NVAX) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -